title: Epidemiology of inflammatory breast cancer (IBC).
abstract: Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer with unknown etiology and generally poor outcome. It is characterized by diffuse edema (peau d'orange) and redness (erythema), although either the disease itself or case definitions have varied over time and place, confounding temporal trends and geographic variations. In this review, we discuss case definitions for IBC and its clinical characteristics; describe its geographic variation, age and racial distribution, incidence and survival patterns, and summarize the very limited information on its epidemiologic risk factors. We also incorporate emerging data from the National Cancer Institute's (NCI) Surveillance, Epidemiology, and End Results (SEER) Program.
authors.affiliation: DHHS/NIH/NCI/DCP, Rockville, MD 20852-7244, USA. wanderso@mail.nih.gov
authors.forename: William F
authors.initials: WF
authors.lastname: Anderson
authors.forename: Catherine
authors.initials: C
authors.lastname: Schairer
authors.forename: Bingshu E
authors.initials: BE
authors.lastname: Chen
authors.forename: Kenneth W
authors.initials: KW
authors.lastname: Hance
authors.forename: Paul H
authors.initials: PH
authors.lastname: Levine
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis* / Q000453:epidemiology* / Q000628:therapy; D000328:Adult; D000367:Age Factors; D000368:Aged; D001707:Biopsy, Needle; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000453:epidemiology* / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D035583:Rare Diseases; D018426:SEER Program; D016019:Survival Analysis; D014481:United States / Q000453:epidemiology